Emory University ( Site 1030) — Atlanta, Georgia

Emory University ( Site 1030) is a clinical research site located in Atlanta, Georgia, United States 30322-1013.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University ( Site 1030) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypertension, Pulmonary.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University ( Site 1030)?

Emory University ( Site 1030) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University ( Site 1030) conducted?

Emory University ( Site 1030) has 1 clinical trials on record, with 1 currently active. Their work covers Hypertension, Pulmonary.

Is Emory University ( Site 1030) accredited by Crixeo Health?

Emory University ( Site 1030) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University ( Site 1030)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.